Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency
Recruiting
VIVUS, Inc.
Phase 2
2020-12-17
The objective of this study is to assess weight stability, functional changes, and quality of
life when Pancreaze (pancrelipase) delayed-release 84,000-lipase units (capsules), for main
meals, and 42,000-lipase units (capsules), for snacks, are added to standard of care in
patients with exocrine pancreatic insufficiency due to pancreatic adenocarcinoma. This will
be the first prospective study of this particular formulation in addition to standard of care
in advanced pancreatic cancer patients. We will treat 45 consecutive patients with borderline
resectable, locally advanced and advanced pancreatic cancer patients who present with weight
loss and exocrine pancreatic insufficiency with this advanced formulation of Pancreaze.
Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency
Recruiting
Andrew Hendifar, MD
Phase 2
2020-12-17
The objective of this study is to assess weight stability, functional changes, and quality of
life when Pancreaze (pancrelipase) delayed-release 84,000-lipase units (capsules), for main
meals, and 42,000-lipase units (capsules), for snacks, are added to standard of care in
patients with exocrine pancreatic insufficiency due to pancreatic adenocarcinoma. This will
be the first prospective study of this particular formulation in addition to standard of care
in advanced pancreatic cancer patients. We will treat 45 consecutive patients with borderline
resectable, locally advanced and advanced pancreatic cancer patients who present with weight
loss and exocrine pancreatic insufficiency with this advanced formulation of Pancreaze.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
